Lung Nodule Intervention Cohort Study

The Efficacy of Transdermal Therapy for Lung nodule---an Real Word Observational Study


Lead Sponsor: Chinese Chronic Respiratory Disease Research Network

Source Chinese Chronic Respiratory Disease Research Network
Brief Summary

Incident lung nodule is quite common in China. The major treatment method is long-term floolow up without a specific intervention. We aim to investigate the efficacy an safty of a novel transdermal therapy with Chinese herb. The study included two arms: one arm is routine treatment and another arm is routine treatment plus transdermal therapy. The study end point is the change of lung nodule size under CT scan.

Overall Status Recruiting
Start Date 2022-01-01
Completion Date 2025-01-01
Primary Completion Date 2022-07-31
Study Type Observational [Patient Registry]
Primary Outcome
Measure Time Frame
change of lung nodule size three months minimal
Enrollment 10000

Intervention Type: Device

Intervention Name: transdermal therapy

Description: transdermal therapy with Chinese medicine


Sampling Method:

Probability Sample


Inclusion Criteria: - incident lung nodule patients Exclusion Criteria: - severe baseline conditions



Minimum Age:

18 Years

Maximum Age:

80 Years

Healthy Volunteers:


Overall Contact

Last Name: xiaohong liu, MD

Phone: +8618364166279

Email: [email protected]

Facility: Status: Contact: Guang An Men Hospital XIAOHONG LIU, MD
Location Countries


Verification Date


Responsible Party

Type: Sponsor

Has Expanded Access No
Acronym LNICS
Study Design Info

Observational Model: Cohort

Time Perspective: Prospective

This information was retrieved directly from the website without any changes. If you have any requests to change, remove or update your study details, please contact [email protected]. As soon as a change is implemented on, this will be updated automatically on our website as well.

Clinical Trials on Incident Lung Nodule

Clinical Trials on transdermal therapy